Clarity Pharmaceuticals Ltd

This study is testing a new two-step treatment for men with advanced prostate cancer that has spread and stopped responding to standard hormone therapy. First, a radioactive scanning drug finds the cancer spots. Then, a related radioactive treatment drug is given to target and da…

This study is testing a new type of PET scan to see how accurately it can detect prostate cancer that has spread to nearby lymph nodes. It will involve about 383 men with high-risk prostate cancer who are scheduled for surgery to remove their prostate. Researchers will compare th…

This study is testing a new type of PET/CT scan to see if it can accurately find prostate cancer that has come back after initial treatment. It will involve about 220 men who have rising PSA levels after surgery or radiation. The main goal is to see how well this new scan detects…